Latest KFF Health News Stories
Democratic Senators Ask Watchdog Agency To Investigate Georgia’s Medicaid Work Rule
A group of Democratic senators asked the Government Accountability Office to examine a Georgia program that requires some Medicaid enrollees to work, study, or volunteer 80 hours a month for coverage. They cited KFF Health News’ reporting, which has documented the program’s high costs and low enrollment.
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” PBMs — or force them to change.
Rage Has Long Shadowed American Health Care. It’s Rarely Produced Big Change.
The outpouring of anger at health insurers following the killing of UnitedHealthcare CEO Brian Thompson continues a cycle of rage that dates back decades.
Native American Patients Are Sent to Collections for Debts the Government Owes
Federal law says Native Americans aren’t liable for medical bills the Indian Health Service promises to pay. Some are billed anyway as a result of backlogs or mistakes from the agency, financial middlemen, or health systems.
Removing a Splinter? Treating a Wart? If a Doctor Does It, It Can Be Billed as Surgery
Minor interventions are increasingly being rebranded and billed as surgery, for profit. This means a neurologist spending 40 minutes with a patient to tease out a diagnosis can be paid less for that time than a dermatologist spending a few seconds squirting a dollop of liquid nitrogen onto the skin.
KFF Health News' 'What the Health?': A Killing Touches Off Backlash Against Health Insurers
The shocking shooting death of UnitedHealthcare’s chief executive in Midtown Manhattan prompted a public outcry about the problems with the nation’s health care system, as stories of delayed and denied care filled social media. Meanwhile, President-elect Donald Trump continues to avoid providing specifics about his plans for the Affordable Care Act and other health issues. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Rachel Cohrs Zhang of Stat join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Francis Collins, who was the director of the National Institutes of Health and a science adviser to President Joe Biden.
Florida’s Canada Drug Importation Plan Has Yet to Launch
Florida Gov. Ron DeSantis (R) spent years complaining that the Biden administration was slow-walking federal approval of his plan to import lower-cost prescription drugs from Canada — a concept endorsed by Donald Trump in 2020 just before his first presidential term ended. But nearly a year since the Food and Drug Administration green-lit the state’s […]
An Arm and a Leg: New Lessons in the Fight for Charity Care
Host Dan Weissmann checks back in on the fight for hospital charity care, with lessons from Dollar For and a savvy listener.
9 States Poised To End Coverage for Millions if Trump Cuts Medicaid Funding
About 3.7 million people are at immediate risk of losing health coverage should the federal government cut funding for Medicaid expansions, as some allies of President-elect Donald Trump have proposed. Coverage could be at risk in the 40 states that have expanded Medicaid.
With Trump on the Way, Advocates Look to States To Pick Up Medical Debt Fight
Patient and consumer advocates fear a new Trump administration will scale back federal efforts to expand financial protections for patients and shield them from debt.
Who Gets Obesity Drugs Covered by Insurance? In North Carolina, It Helps If You’re on Medicaid
GLP-1 agonist medications such as Ozempic accounted for 10% of the North Carolina state employee health plan’s prescription drug spending, so the state is no longer covering them for weight loss alone. Still, it did decide to cover them for Medicaid patients’ weight loss. A look inside the state’s coverage calculus.
¿Podrían los nuevos medicamentos para bajar de peso estar disponibles para todos?
Los medicamentos agonistas GLP-1, conocidos por los nombres comerciales Ozempic, Trulicity y Wegovy, han demostrado ser efectivos para la pérdida de peso y para el manejo de la diabetes tipo 2.
A Toddler Got a Nasal Swab Test but Left Before Seeing a Doctor. The Bill Was $445.
A mom in Peoria, Illinois, took her 3-year-old to the ER one evening last December. While they were waiting to be seen, the toddler seemed better, so they left without seeing a doctor. Then the bill came.
Florida’s Deloitte-Run Computer System Cut Off New Moms Entitled to Medicaid
Florida discovered a glitch in its Deloitte-run Medicaid eligibility system. The problem, alleged in court testimony, led to new mothers wrongly losing their insurance coverage.
Indiana Hospitals Pull Merger Application After Pushback Over Monopoly Concerns
Two Indiana hospital rivals withdrew their application to merge after facing pushback from the Federal Trade Commission and the public.
Dicen que los esfuerzos contra el fraude en ACA han dado resultados. Pero hay que estar alerta
Los Centros de Servicios de Medicare y Medicaid atribuyen esta reducción a las medidas adoptadas para prevenir problemas de inscripción y cambios de planes, que ya habían generado más de 274,000 quejas hasta agosto.
Journalists Reflect on Trump Picks, Racism and Public Health, and Unnecessary Dental Implants
KFF Health News staff made the rounds on national and local media in the last two weeks to discuss topical stories. Here’s a collection of their appearances.
Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval
Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.
El plan del gobernador de Florida para importar medicamentos más baratos de Canadá sigue en la nada
Florida solicitó crear un programa de importación en noviembre de 2020, pocos meses después que la administración Trump concediera esta opción a los estados.
California Sets 15% Target for Primary Care Spending Over Next Decade
The state Office of Health Care Affordability has set a goal for insurers to direct 15% of their spending to primary care by 2034, part of a push to expand preventive care services. Health plans say it’s unclear how the policy will mesh with the state’s overarching goal to slow spending growth.
